Journal rankings · indicator year 2002
Choose a field to open its ranking, or a journal to find its row in its subfield’s list.
Field ranking · 2002
Biochemistry, Genetics and Molecular Biology journal rankings 2002
696 ranked journals · Field in Life Sciences
Biochemistry, Genetics and Molecular Biology has 696 ranked journals in 2002. The median OJR rose 0.05 on 2001 to 0.68, below the world average of 1.00; Q1 starts at OJR 1.19. The top three are Annual Review of Plant Physiology and Plant Molecular Biology, Pharmacological Reviews, and Cell.
Ranks and citation indicators: 2002. Journal access status and listed APC: source snapshot September 23, 2026.
Journals whose main subfield sits in this category and that published at least 30 citable documents (articles, reviews and conference papers) in 1999–2001, the window the 2002 score is computed on.
The OpenJournalRank Indicator (OJR) is a free, publicly available metric of a journal’s field-normalized citation impact, computed from open OpenAlex citation data. It compares citations to a journal’s papers from the previous three years with the world average for papers of the same subfield, year and type, so 1.00 is the world average and values can be compared across fields. It is computed with the NCI3 method.
The middle OJR among ranked journals in this category: half score higher, half lower. 1.00 is the world average for papers of the same subfield, year and type.
The dot is this category, the solid tick is the median of all ranked journals and the dashed line is the world average.
Share of ranked journals in this category that are fully open access, so every paper is free to read. Hybrid journals, which sell subscriptions and open single papers for a fee, are not counted.
Median list price of the article processing charge, in US dollars, among ranked journals in this category that list a price above zero. Journals with a listed APC of $0 and journals with no known price are left out of this median. The At a glance table below gives a second median that includes the $0 prices.
Subfields in Biochemistry, Genetics and Molecular Biology (14)
Up to Life Sciences696 ranked journals
Filters
Rank is the position by OJR within the list on screen; 1 is the highest. | OJR is field-normalized 3-year citation impact: 1.00 is the world average for papers of the same subfield, year and type, so values compare across fields. The badge is the journal’s quartile in this list. | Citations per paper over a two-year window, counted from OpenAlex. It is not field-normalized, so compare it only between journals of the same field. ▲ or ▼ is the change from 2001. This is OpenJournalRank’s own count, not Clarivate’s Journal Impact Factor. | Citable documents (articles, reviews and conference papers) published in 1999–2001, the window the 2002 OJR is computed on. A journal needs at least 30 to be ranked. | Share of the journal’s 1999–2001 papers that are free to read in any open-access form. The green OA tag next to a title marks a fully open-access journal. | List price of the article processing charge in US dollars. “$0 listed” means the listed price is zero; a dash means no price is listed. | The line is the journal’s OJR from 2000 to 2002. | Compare |
|---|---|---|---|---|---|---|---|
1Annual Review of Plant Physiology and Plant Molecular BiologyAnnual Reviews · United States | 10.64Q1 | 15.71 3.38 down from 2001 | 74 | — | — | ||
2Pharmacological ReviewsAmerican Society for Pharmacology and Experimental Therapeutics · United States | 10.09Q1 | 21.58 2.43 up from 2001 | 72 | 3% | $4,500 | ||
3CellCell Press · United States | 9.79Q1 | 25.46 1.22 down from 2001 | 1,198 | 98% | $11,400 | ||
4Nature GeneticsNature Portfolio · United States | 7.74Q1 | 18.31 1.54 down from 2001 | 1,133 | 15% | $12,690 | ||
5Annual Review of Biophysics and Biomolecular StructureAnnual Reviews · United States | 7.11Q1 | 16.15 0.27 up from 2001 | 53 | 19% | — | ||
6NatureNature Portfolio · United Kingdom | 6.77Q1 | 10.49 1.31 up from 2001 | 9,211 | 10% | $12,690 | ||
7Molecular CellElsevier BV · United States | 5.86Q1 | 16.00 0.12 up from 2001 | 745 | 88% | $10,400 | ||
8Nature Cell BiologyNature Portfolio · United Kingdom | 5.23Q1 | 13.96 0.37 down from 2001 | 730 | 14% | $12,690 | ||
9Journal of Clinical InvestigationOAAmerican Society for Clinical Investigation · United States | 4.74Q1 | 10.72 1.79 down from 2001 | 1,577 | 68% | $5,200 | ||
10ScienceAmerican Association for the Advancement of Science · United States | 4.57Q1 | 5.93 0.04 up from 2001 | 13,227 | 4% | — | ||
11Proceedings of the National Academy of SciencesNational Academy of Sciences · United States | 4.44Q1 | 10.44 0.20 up from 2001 | 8,509 | 99% | — | ||
12The EMBO JournalOASpringer Nature · Germany | 4.35Q1 | 11.29 1.42 down from 2001 | 2,051 | 96% | $7,990 | ||
13The Journal of Cell BiologyRockefeller University Press · United States | 4.12Q1 | 11.13 0.82 down from 2001 | 1,712 | 100% | — | ||
14Human Molecular GeneticsOxford University Press · United Kingdom | 3.72Q1 | 9.67 0.02 up from 2001 | 971 | 16% | $4,390 | ||
15Progress in Lipid ResearchElsevier BV · United Kingdom | 3.69Q1 | 8.91 4.24 up from 2001 | 48 | 0% | $5,530 | ||
16Circulation ResearchLippincott Williams & Wilkins · United States | 3.42Q1 | 8.78 0.58 up from 2001 | 1,142 | 50% | — | ||
17Developmental CellElsevier BV · United States | 3.23Q1 | 8.14no 2001 value | 97 | 100% | $10,400 | — | |
18The American Journal of Human GeneticsElsevier BV · United States | 3.17Q1 | 8.88 1.22 up from 2001 | 1,374 | 86% | $5,150 | ||
19Progress in Biophysics and Molecular BiologyElsevier BV · United Kingdom | 3.15Q1 | 5.24 2.80 down from 2001 | 67 | 100% | $4,260 | ||
20TrAC Trends in Analytical ChemistryElsevier BV · Netherlands | 3.07Q1 | 3.31 0.64 down from 2001 | 225 | 5% | $5,150 | ||
21FEMS Microbiology ReviewsOAOxford University Press · Netherlands | 3.05Q1 | 6.11 1.35 up from 2001 | 182 | 35% | $3,297 | ||
22Molecular and Cellular BiologyTaylor & Francis · United States | 3.04Q1 | 8.76 0.51 down from 2001 | 2,660 | 100% | — | ||
23Annual Review of BiochemistryAnnual Reviews · United States | 3.02Q1 | 38.41 3.24 up from 2001 | 84 | 20% | — | ||
24Systematic BiologyOxford University Press · United States | 2.98Q1 | 4.42 1.57 down from 2001 | 263 | 32% | $2,166 | ||
25American Journal Of PathologyElsevier BV · United States | 2.86Q1 | 6.65 0.20 down from 2001 | 1,386 | 100% | $2,800 | ||
26DevelopmentThe Company of Biologists · United Kingdom | 2.85Q1 | 8.75 0.51 down from 2001 | 1,471 | 11% | — | ||
27Nature BiotechnologyNature Portfolio · United States | 2.83Q1 | 5.85 1.77 up from 2001 | 1,461 | 14% | $12,690 | ||
28Cellular MicrobiologyOAWiley · United Kingdom | 2.79Q1 | 5.39 0.82 up from 2001 | 159 | 63% | $2,350 | ||
29Pharmacology & TherapeuticsElsevier BV · United States | 2.67Q1 | 5.38 0.21 up from 2001 | 211 | 0% | $5,660 | ||
30Seminars in Cell and Developmental BiologyElsevier BV · Netherlands | 2.64Q1 | 6.04 0.91 up from 2001 | 195 | 4% | $4,670 | ||
31Molecular MicrobiologyWiley · United Kingdom | 2.55Q1 | 5.85 0.15 down from 2001 | 1,561 | 54% | $4,430 | ||
32The FASEB JournalWiley · United States | 2.52Q1 | 5.58 0.82 down from 2001 | 1,299 | 5% | $3,740 | ||
33Applied and Environmental MicrobiologyOAAmerican Society for Microbiology · United States | 2.50Q1 | 4.01 0.29 up from 2001 | 2,702 | 95% | — | ||
34Physiological ReviewsAmerican Physiological Society · United States | 2.48Q1 | 28.14 1.69 up from 2001 | 123 | 4% | — | ||
35Molecular Biology of the CellAmerican Society for Cell Biology · United States | 2.44Q1 | 7.30 0.07 up from 2001 | 1,023 | 87% | — | ||
36Current Medicinal ChemistryBentham Science Publishers · Netherlands | 2.42Q1 | 4.09 0.32 down from 2001 | 269 | 3% | — | ||
37Mutation Research/Reviews in Mutation ResearchElsevier BV · Netherlands | 2.40Q1 | 6.81 2.14 up from 2001 | 101 | 3% | $4,160 | ||
38NeoplasiaOAElsevier BV · United Kingdom | 2.38Q1 | 6.69 3.27 up from 2001 | 169 | 100% | $3,530 | ||
39EMBO ReportsOASpringer Nature · Germany | 2.34Q1 | 5.20 1.58 up from 2001 | 341 | 95% | $7,990 | ||
40Arteriosclerosis Thrombosis and Vascular BiologyLippincott Williams & Wilkins · United States | 2.34Q1 | 6.13 0.88 up from 2001 | 1,231 | 47% | — | ||
41Journal of Biological ChemistryOAElsevier BV · United States | 2.33Q1 | 6.90 0.30 down from 2001 | 17,515 | 99% | $3,430 | ||
42Gene TherapySpringer Nature · United Kingdom | 2.32Q1 | 5.73 0.23 up from 2001 | 792 | 7% | $3,790 | ||
43Free Radical Biology and MedicineElsevier BV · United Kingdom | 2.31Q1 | 4.90 0.31 up from 2001 | 1,105 | 2% | $4,240 | ||
44Analytical ChemistryAmerican Chemical Society · United States | 2.31Q1 | 3.48 0.37 up from 2001 | 3,509 | 7% | $4,500 | ||
45Journal of Computational BiologyMary Ann Liebert, Inc. · United States | 2.30Q1 | 6.28 2.67 up from 2001 | 121 | 6% | — | ||
46Molecular Biology and EvolutionOAOxford University Press · United States | 2.28Q1 | 5.12 0.23 down from 2001 | 650 | 64% | $3,418 | ||
47StructureElsevier BV · United Kingdom | 2.25Q1 | 5.18 0.49 down from 2001 | 501 | 100% | $9,350 | ||
48BioinformaticsOAOxford University Press · United Kingdom | 2.25Q1 | 5.93 1.45 up from 2001 | 553 | 59% | $3,989 | ||
49Journal of Cell ScienceThe Company of Biologists · United Kingdom | 2.22Q1 | 6.46 0.57 up from 2001 | 1,416 | 15% | — | ||
50Biochimica et Biophysica Acta (BBA) - Reviews on CancerElsevier BV · Netherlands | 2.22Q1 | 6.59 1.83 up from 2001 | 82 | 0% | $5,070 |
Subfields of Biochemistry, Genetics and Molecular Biology, compared.
- Molecular Biology586
- Genetics64
- Cancer Research15
- Cell Biology13
- Biophysics6
- Molecular Medicine5
- Biochemistry2
- Clinical Biochemistry2
- Aging1
- Developmental Biology1
- Structural Biology1
- Biotechnology0
- Endocrinology0
- Physiology0
Journals
Citations made in 2002. Corpus-wide, 69.2% of core-journal articles and reviews published that year have at least one matched reference; the share varies by journal and field.
219 additional Biochemistry, Genetics and Molecular Biology journals with metrics are unranked under this release’s eligibility rules: a journal needs at least 30 citable documents in 1999–2001, at least 80% of them with a subfield, and a positive world-average expectation. Ranks are within the whole category; filters hide rows without re-ranking. OJR excludes self-citations.
At a glance
Indicator year: 2002. Publication window: 1999–2001. How these summaries are calculated
- Ranked journals
- 696
- Window papers (baseline)
- 354,210 Change unavailable from indicator year 1999
- Median OJR
- 0.68 Change unavailable from indicator year 1999
- Rising journals (2025)
- 141Comparison-group list (141)
Window papers are the baseline paper population: citable papers (articles, reviews and conference papers) from 1999–2001 in all journals of the world-average baseline, including non-core journals, counted by each paper’s own subfield. They are not the papers of the ranked journals alone.
| Measure | Year series | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ranked journals | 609 | 650 | 696 | 742 | 765 | 806 | 835 | 888 | 919 | 951 | 1,003 | 1,064 | 1,125 | 1,172 | 1,217 | 1,271 | 1,311 | 1,339 | 1,365 | 1,369 | 1,349 | 1,339 | 1,358 | 1,366 | 1,355 | 1,367 | |
| Window papers (baseline) | 310,927 | 335,262 | 354,210 | 375,343 | 388,415 | 415,247 | 441,606 | 472,036 | 497,712 | 532,780 | 565,943 | 595,190 | 615,359 | 631,115 | 652,778 | 672,042 | 683,714 | 684,441 | 678,826 | 679,352 | 690,127 | 717,801 | 750,552 | 768,440 | 764,327 | 768,613 | |
| Median OJR | 0.628 | 0.634 | 0.68 | 0.76 | 0.81 | 0.8465 | 0.872 | 0.894 | 0.921 | 0.95 | 0.98 | 1.03 | 1.02 | 0.990 | 0.986 | 0.97 | 0.96 | 0.93 | 0.925 | 0.915 | 0.912 | 0.90 | 0.890 | 0.8474 | 0.853 | 0.871 |
| Measure | Category statistic | Eligible population |
|---|---|---|
| Journal self-citation share | Median: 1.9% | 1,206 journals |
| Retracted papers per 1,000 | Pooled rate: 4.798 per 1,000 | 1,059 journals |
| Output growth | Median: -6.4% | 1,233 journals |
| Open access share | Median: 100.0% | 1,367 journals |
| Listed APC (USD) | Median including $0 listed prices: $3,300 | 943 ranked journals with a known listed price, including $0 listed prices |
| International collaboration share | Median: 24.4% | 1,335 journals |
| Review share | Median: 0.3% | 1,367 journals |
| Articles-only OJR | Median: 0.87 | 1,336 journals |
| Uncited share | Median: 22.7% | 1,367 journals |
| Citation concentration | Median: 42.1% | 1,363 journals |
How to read these rankings
- OJR, the OpenJournalRank Indicator
- A field-normalized 3-year citation impact, computed from OpenAlex with the NCI3 method. It divides the citations a journal’s papers received by the world average for papers of the same subfield, year and type, so 1.00 is the world average and 2.00 means twice as many citations as expected. Because it is normalized, it can be compared across fields. Read the methodology
- Quartiles
- Q1 to Q4 split the ranked journals of the list you are viewing into four equal groups by OJR. A journal’s quartile depends on the list: the same journal can be Q1 in its subfield and Q2 among all journals.
- Impact factor (2-year)
- Citations per paper over a two-year window, counted from OpenAlex. It is easy to compare with familiar impact factors but is not field-normalized, so compare it only within a field. It is not Clarivate’s Journal Impact Factor. Why it differs from the Journal Impact Factor
- Rank ranges
- Each rank in the latest year carries a likely range from 1,000 resamples of the journal’s papers. Where two journals’ ranges overlap, the data cannot tell them apart, so treat neighbouring ranks as ties.